Associated Papers
Performance and considerations in the use of diagnostic mutation panels for clonality testing in non-small-cell lung carcinoma.
Janssen J et al.
Esmo Open, 2025
40373350 (PubMed )
Supplement: mmc4.xlsx › 4c_Correctly_classified
Delineating the RAS Conformational Landscape.
Parker MI et al.
Cancer Research, 2022
35536216 (PubMed )
Supplement: can-22-0804_supplementary_datasets_s1-s4_suppsds1-sds4.xlsx › Supplementary_Dataset_S1
Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine-dependent interface: a model for KRAS oligomerization.
Lee KY et al.
Chemical Science, 2021
34703570 (PubMed )
Supplement: SC-012-D1SC03484G-s001.pdf
NMR in integrated biophysical drug discovery for RAS: past, present, and future.
Marshall CB et al.
Journal of Biomolecular Nmr, 2020
Select a paper to view details